ESTROGEN REGULATION OF SMOOTH MUSCLE BKCA CHANNELS
雌激素对平滑肌 BKCA 通道的调节
基本信息
- 批准号:6719855
- 负责人:
- 金额:$ 25.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-02-01 至 2005-01-31
- 项目状态:已结题
- 来源:
- 关键词:Xenopus oocyte biological signal transduction cGMP dependent protein kinase calcium ion electrophysiology enzyme activity estrogen receptors estrogens gene expression gene targeting genetically modified animals guanylate cyclase hormone regulation /control mechanism ion channel blocker laboratory mouse myocardial ischemia /hypoxia nitric oxide synthase phosphorylation potassium channel protein structure function tissue /cell culture transcription factor vascular endothelium vascular smooth muscle vasodilatation
项目摘要
Estrogen protects the cardiovascular system from injury by complex mechanisms that have both short- and long-term components. Longer- term estrogen actions occurs following hours of estrogen exposure and is mediated by estrogen receptors acting in the nucleus as transcription factors for growth-related genes. The rapid effects of estrogen, by contrast, occurs in a seconds-to-minutes time frame and do not require gene transcription. Project 5 of the SCOR application addresses the molecular mechanisms underlying one of the most important of these rapid effects-vasodilation. The signaling pathways underlying this non- genomic action of estrogen are incompletely understood but new data support they involve the action of nitric oxide synthase in vascular cells, elevation of nitric oxide, stimulation of vascular smooth muscle cell soluble guanylyl cyclase, and substrate phosphorylation by cGMP- dependent protein kinase (PKG). Although the key substrate(s) for PKG is unknown, new data support one likely possibility is the smooth muscle large conductance Ca2+-activated K+ (BKCa) channel. Blockade of BKCa channels in vascular rings significantly reduces estrogen-induced vasodilation, demonstrating the central role that BKCa channels in vascular rings significantly reduces estrogen-induced vasodilation, demonstrating the central role that BKCa channels play in the acute physiological response to estrogen. Experiments in Aim 1 will use BKCa channels in vascular rings significantly reduces estrogen-induced vasodilation, demonstrating the central role that BKCa channels play in the acute physiological response to estrogen. Experiments in Aim 1 will use BKCa channel activity recorded from single smooth muscle cells dissociated from mouse aorta as an assay for characterizing upstream elements in the estrogen signaling pathway that targets BKCa channels. Experiments will assess the relative contributions of endothelial and smooth muscle cells, the types of estrogen receptor involved, and the requirement for nitric oxide synthase activation. Experiments in Aim 2 will focus on the molecular mechanism by which BKCa channel activity is regulated by estrogen. We will identify the molecular variants of BKCa channel activity is regulated by estrogen. We will identify the molecular variants. variants of BKCa channels that are expressed in smooth muscles cells from mouse aorta and study the recombinant channels expressed heterologously in order to test the hypothesis that estrogen brings about BKCa channel activation through a direct PKG-dependent phosphorylation of the channel protein. Such information is essential to further understand the protective effects of estrogen on vascular tissue and may form the basis for development of new therapies for cardiovascular disease.
雌激素可保护心血管系统免受短期和长期成分的复杂机制的伤害。长期雌激素的作用发生在雌激素暴露小时后发生,并由作用在细胞核中作为生长相关基因转录因子的雌激素受体介导。相比之下,雌激素的快速作用发生在几秒钟到一分钟的时间范围内,不需要基因转录。 SCOR应用程序的项目5解决了这些快速效应 - 舒张中最重要的分子机制。雌激素的这种非基因组作用的信号传导途径尚不完全理解,但是新数据支持它们涉及一氧化氧化物合酶在血管细胞中的作用,一氧化氮的升高,刺激血管平滑肌细胞细胞的刺激,抑制胰鸟类环鸟乳凝酶环鸟叶糖环酶,以及CGMP-protents Protents protents protent kiteins kinasase(Pkeg)Kinasase(Pkeg)Kinase(Pken)Kinase(Pken)Kinase(Pkeg)Kinase(Pken)。尽管PKG的关键底物尚不清楚,但新的数据支持一种可能性是平滑肌大电导Ca2+激活的K+(BKCA)通道。血管环中BKCA通道的阻塞可显着减少雌激素诱导的血管舒张,这表明BKCA通道在血管环中显着降低了雌激素诱导的血管舒张,这表明BKCA通道在对雌激素的急性物理学反应中起着BKCA通道的中心作用。 AIM 1中的实验将在血管环中使用BKCA通道可显着降低雌激素诱导的血管舒张,这表明BKCA通道在对雌激素的急性生理反应中所起的核心作用。 AIM 1中的实验将使用从小鼠主动脉解离的单个平滑肌细胞中记录的BKCA通道活性,以表征针对BKCA通道的雌激素信号通路中上游元件。实验将评估内皮细胞和平滑肌细胞的相对贡献,所涉及的雌激素受体的类型以及一氧化氮合酶激活的需求。 AIM 2中的实验将集中在BKCA通道活性受雌激素调节的分子机制上。我们将确定BKCA通道活性的分子变体受雌激素调节。我们将确定分子变体。 BKCA通道的变体来自小鼠主动脉的平滑肌细胞中,并研究重组通道异源表达的重组通道,以检验雌激素通过通道蛋白的直接PKG依赖性磷酸化引起BKCA通道激活的假设。这种信息对于进一步了解雌激素对血管组织的保护作用至关重要,并可能构成开发新疗法的心血管疾病的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen Dunlap其他文献
Kathleen Dunlap的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen Dunlap', 18)}}的其他基金
GABA-B Receptors as Regulators of Islet Biology
GABA-B 受体作为胰岛生物学的调节剂
- 批准号:
6574939 - 财政年份:2002
- 资助金额:
$ 25.07万 - 项目类别:
GABA-B Receptors as Regulators of Islet Biology
GABA-B 受体作为胰岛生物学的调节剂
- 批准号:
6665345 - 财政年份:2002
- 资助金额:
$ 25.07万 - 项目类别:
Synaptic Defects in the Ca Channel Mutant Mouse
Ca 通道突变小鼠的突触缺陷
- 批准号:
6639741 - 财政年份:2001
- 资助金额:
$ 25.07万 - 项目类别:
Synaptic Defects in the Ca Channel Mutant Mouse
Ca 通道突变小鼠的突触缺陷
- 批准号:
6540405 - 财政年份:2001
- 资助金额:
$ 25.07万 - 项目类别:
Synaptic Defects in the Ca Channel Mutant Mouse
Ca 通道突变小鼠的突触缺陷
- 批准号:
6319484 - 财政年份:2001
- 资助金额:
$ 25.07万 - 项目类别:
Synaptic Defects in the Ca Channel Mutant Mouse
Ca 通道突变小鼠的突触缺陷
- 批准号:
6764061 - 财政年份:2001
- 资助金额:
$ 25.07万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Novel downstream effectors of protein kinase G in hypertensive disease
高血压疾病中蛋白激酶 G 的新型下游效应子
- 批准号:
10228381 - 财政年份:2021
- 资助金额:
$ 25.07万 - 项目类别:
Illuminating the functions and translational potential of CDC42BP/MRCK kinases in ovarian cancer
阐明 CDC42BP/MRCK 激酶在卵巢癌中的功能和翻译潜力
- 批准号:
10216717 - 财政年份:2021
- 资助金额:
$ 25.07万 - 项目类别:
Novel downstream effectors of protein kinase G in hypertensive disease
高血压疾病中蛋白激酶 G 的新型下游效应子
- 批准号:
10593096 - 财政年份:2021
- 资助金额:
$ 25.07万 - 项目类别:
Novel downstream effectors of protein kinase G in hypertensive disease
高血压疾病中蛋白激酶 G 的新型下游效应子
- 批准号:
10380140 - 财政年份:2021
- 资助金额:
$ 25.07万 - 项目类别:
Novel Mechanisms of Hypertensive Kidney Injury and Fibrosis
高血压肾损伤和纤维化的新机制
- 批准号:
9487887 - 财政年份:2015
- 资助金额:
$ 25.07万 - 项目类别: